Skip to content

Budesonide EP Impurity D

Budesonide EP Impurity D

Product Description
CAT No.
ALN-B022005
CAS No.
85234-63-5
Mol. F.
C25H32O6
Mol. Wt.
428.5
Stock
Please Inquire
Chemical Name : 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-3,20-dioxopregna-1,4-dien-21-al (as per EP & USP)
Smiles : C[C@@]12[C@@]3(C(C=O)=O)[C@@](O[C@@](O3)([H])CCC)([H])C[C@@]1([H])[C@]4([H])CCC5=CC(C=C[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O.C[C@@]67[C@@]8(C(C(O)O)=O)[C@@](O[C@@](O8)([H])CCC)([H])C[C@@]6([H])[C@]9([H])CCC%10=CC(C=C[C@]%10(C)[C@@]9([H])[C@@H](O)C7)=O
Inchi : InChI=1S/C25H34O6/c1-4-5-20-30-19-11-17-16-7-6-14-10-15(27)8-9-23(14,2)21(16)18(28)12-24(17,3)22(29)25(19,13-26)31-20/h8-10,16-21,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,19+,20?,21+,23-,24-,25+/m0/s1
Synonym : 21-dehydrobudesonide (USP) ; Budesonide Aldehyde Impurity

A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers

By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852

Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC

By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6

Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy

By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461

Request For Quotation